|
|
|
Quick Links
|
North CarolinaON THIS PAGE: University of North Carolina General Clinical Research Center Web site: http://verne.med.unc.edu Grant No. M01 RR00046 Special Assays, Services, or Tests Detailed dietary analysis (calories, protein,
carbohydrates, fats, Na, K, Ca, PO4), choline, d-chiro
inositol Special Resources, Instruments, or Services Body composition laboratoryDEXA, indirect
calorimeter, bioelectrical impedance analysis (BIA), anthropometrics Major Areas of InvestigationCardiology: Noninvasive evaluation of cardioactive drugs; neurohumoral factors in heart failure; therapy of hypercholesterolemia. Cystic Fibrosis: Development and testing of novel therapeutic approaches, including aerosolized amiloride and adenine nucleotides; gene therapy; role of atypical mycobacterial infection. Dentistry: Role of oral inflammation in systemic diseases. Dermatology: Pathogenesis of epidermolysis bullosa, bullous pemphigoid, and other bullous skin diseases. Endocrinology: Growth hormone and insulin-like growth factors (IGF) in pituitary disorders; nutritional regulation of IGF and IGF-binding protein production; growth hormone therapy of short but GH-sufficient children; use of GH in obese subjects; diagnostic test evaluation in Cushing's syndrome; regulation of TSH secretion; GH and IGF-I in HIV. Gastroenterology: Therapy of inflammatory bowel disease; localization of intestinal sites of drug absorption; case-control study of colonic tumor patients; hepatitis B and C therapy; Norwalk virus challenge; drug-induced liver disease. Gynecology: Molecular predictors of natural history of uterine fibroids; gynecologic oncology group treatment protocols for cancer of the ovary, uterus, and fallopian tubes. Hematology and Oncology: Gene therapy for hemophilia; novel therapies for sickle cell anemia; proteosome inhibitors in the treatment of hematological and solid malignancies; molecular predictors of tumor response to treatments; adoptive immunotherapy of malignancies. HIV and AIDS: Treatment for HIV-1 infection with antiretroviral compounds and immune modulators including IL-2 and thalidomide; treatment for AIDS-related opportunistic infections including Pneumocystis carinii pneumonia, Mycobacterium-avium intracellulare, aphthous ulcers, particularly cytomegalovirus infections and cryptococcal infections; therapy of HIV-1 including treatment with protease inhibitors and nonnucleoside compounds; treatment of membrane attack complex, resistant herpes simplex virus infections, and cryptococcal meningitis; treatment of pediatric HIV-1 infection and AIDS, including therapeutic protocols and other nucleoside analogues; evaluation of therapies to prevent HIV-1 transmission from seropositive pregnant women to their infants; treatment of HIV-1-related malignancies; neurologic consequences of HIV-1 infection; psychiatric and social impact of HIV-1 infection and of HIV-1 high-risk behavior, especially in men who have sex with men; pharmacokinetic studies of medications used in treatment of HIV and HIV-related opportunistic infections. Infectious Diseases: Hepatitis infection in hemophiliacs; sexually transmitted diseases, including studies in gonorrheal pathogenesis and vaccine development; antifungal therapy in the immunocompromised host. Neurology: Sensory-evoked potential changes in nervous system dysfunction and anticonvulsant drug withdrawal; evaluation of new anticonvulsant drugs; evaluation of CNS function in HIV-positive patients. Pharmacology: Molecular determinants of drug disposition; use of probe drugs to determine drug metabolism enzyme/transporter phenotype. Psychiatry: Neurohumoral effects of chlorimipramine and oxytocin; antidepressant drug effects in noradrenergic and serotoninergic systems; renal and cardiovascular effects of psychological stress; coping in patients with HIV infection; postpartum depression; coping in sickle cell disease. Pulmonary Disorders: Pathophysiology of reactive airways disease; treatment of asthma. Surgery: Chemotherapy of brain tumor following surgery; active immunotherapy for anaplastic gliomas. Women's Health: Hormone replacement therapy; dietary modification; calcium and vitamin D supplementation; factors involved in preterm birth. Contact InformationFor information about this GCRC and how to access its resources, please contact: Administrative Director Program Director Principal Investigator Associate Program Director Associate Program Director Associate Program Director (Dentistry) Core Laboratory Director Research Subject Advocate, Epidemiologist Research Subject Advocate GCRC Advisory Committee Chairperson Nurse Manager Training and Career Development Nutrition Research Manager Biostatistician Computer Systems Manager Wake Forest University School of Medicine General Clinical Research Center Web site: www.gcrc.wfubmc.edu Grant No. M01 RR07122 Special Resources, Instruments, or Services Ankle and brachial blood pressure indices Food frequency administration and analysis Major Areas of InvestigationAnesthesiology: New spinal anesthetic agents for childbirth and chronic pain. Cardiovascular Diseases: Treatments for peripheral arterial disease; hypertension and salt sensitivity; exercise training and congestive heart failure; multiethnic study of atherosclerosis; ACE inhibition and novel cardiovascular risk factors; diastolic heart failure. Dermatology: Psoriasis; reinforcing properties of UV light in tanning bed users. Endocrinology: Diabetes prevention trial; inhaled insulin versus subcutaneous insulin therapy in diabetes; LDL cholesterol-lowering drugs in hypercholesterolemia. Gastroenterology: Responses to dietary fat and cholesterol; oxalate studies; virtual colonoscopy. Genetics: Genetic epidemiology of diabetic cardiovascular disease; molecular epidemiology of breast cancer and prostate cancer; genes and chronic obstructive pulmonary disease; genetics of bone in type 2 diabetes. Geriatrics and Gerontology: Arthritis, diet, and activity promotion; depression in the elderly; resistance training in older adults; diet, exercise, and metabolism in older women. Hematology and Oncology: Prostate cancer prevention; diphtheria fusion toxin therapy of myeloid leukemia; recovery in breast cancer; chemotherapy-induced cardiomyopathy and MRI. Infectious Diseases: Cellular mechanisms of septic shock. Nephrology: Hemodialysis and quality of life; progression of renovascular disease in the elderly. Neurology: Treatment of chronic inflammatory demyelinating polyneuropathy; amyotrophic lateral sclerosis; Huntington's disease. Obstetrics and Gynecology: Ovarian cancer screening study; fatty acids and preterm birth; folic acid load in pregnant epileptic women. Pediatrics: Ventilation in very-low-birthweight infants; cystic fibrosis, sinusitis; bone strength in children; effect of postnatal dexamethasone on children at school age. Physiology and Pharmacology: Regional brain activation during cocaine abstinence. Psychiatry: Optimization of electroconvulsive therapy for depression. Pulmonary Diseases: Lipid pathways and lung injury; asthma studies; lung cancer screening. Rheumatology: Systemic lupus erythematosus; T cells. Urology: Role of oxalate in nephrolithiasis. Women's Health: Women's Health Initiative (WHI); WHI memory study (WHIMS). Contact InformationFor information about this GCRC and how to access its resources, please contact: Administrative Director Program Director Principal Investigator Associate Program Director Associate Program Director Associate Program Director Research Subject Advocate GCRC Advisory Committee Chairperson Research Nurse Manager Bionutrition Research Manager Processing Lab Manager Molecular Genetics Core Director Biostatistician Informatics Core Manager |
| National Institutes of Health (NIH) Bethesda, Maryland 20892 |
Department of Health and Human Services |